Skip to main content
Log in

Canavan disease – unusual imaging features in a child with mild clinical presentation

  • Case Report
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Canavan disease is a rare hereditary leukodystrophy that manifests in early childhood. Associated with rapidly progressive clinical deterioration, it usually results in death by the third year of life. The predominant MRI appearance is diffuse and symmetrical white matter disease. We discuss an atypical, late presentation of Canavan disease with a benign clinical course and uncharacteristic imaging features. This case introduces a previously unreported pattern of diffuse cortical abnormality without significant white matter involvement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Feigenbaum A, Moore R, Clarke J (2004) Canavan disease: carrier-frequency determination in the Ashkenazi Jewish population and development of a novel molecular diagnostic assay. Am J Med Genet A 124:142–147

    Article  Google Scholar 

  2. Matalon R, Michals-Matalon K (1993) Canavan disease. In: Pagon RA, Adam MP, Bird TD et al. (eds) GeneReviews, Seattle, WA

  3. Mathew R, Arun P, Madhavarao CN et al (2005) Progress toward acetate supplementation therapy for Canavan disease: glyceryl triacetate administration increases acetate, but not N-acetylaspartate, levels in brain. J Pharmacol Exp Ther 315:297–303

    Article  CAS  PubMed  Google Scholar 

  4. Barkovich AJ, Raybaud C (2012) Pediatric neuroimaging. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  5. Baslow MH, Guilfoyle DN (2013) Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions. Biochimie 95:946–956

    Article  CAS  PubMed  Google Scholar 

  6. Leone P, Shera D, McPhee SW et al. (2012) Long-term follow-up after gene therapy for canavan disease. SciTransl Med 4:165ra163

  7. Janson CG, Kolodny EH, Zeng BJ et al (2006) Mild-onset presentation of Canavan’s disease associated with novel G212A point mutation in aspartoacylase gene. Ann Neurol 59:428–431

    Article  CAS  PubMed  Google Scholar 

  8. Velinov M, Zellers N, Styles J et al (2008) Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan’s disease. Clin Genet 73:288–289

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ho V. Nguyen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nguyen, H.V., Ishak, G.E. Canavan disease – unusual imaging features in a child with mild clinical presentation. Pediatr Radiol 45, 457–460 (2015). https://doi.org/10.1007/s00247-014-3116-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-014-3116-8

Keywords

Navigation